yebN is typically expressed in E. coli systems due to its hydrophobic nature, which complicates heterologous expression. Key steps include:
Purification: Affinity chromatography (e.g., nickel-NTA columns for His-tagged proteins) followed by refolding or detergent-based solubilization .
Yield: Not explicitly quantified in available studies, but comparable protocols for Shigella membrane proteins report yields of 1–6 mg/L culture .
Hydrophobicity may necessitate mild detergents (e.g., CHAPS, DDM) to maintain solubility .
Potential aggregation during expression, mitigated by co-expression with chaperones (e.g., IpgC for IpaB) .
yebN is included in Generalized Modules of Membrane Antigens (GMMA), a vaccine platform for Shigella sonnei that incorporates outer membrane proteins. Key findings:
Strain Engineering: S. sonnei NVGH1859 (ΔtolR::kan, ΔvirG::nadAB) retains the virulence plasmid encoding O-antigen and yebN due to nicotinic acid auxotrophy removal .
Immunogenicity: GMMA vaccines containing yebN elicited strong anti-LPS responses in mice and rabbits, with minimal pyrogenic activity .
Reactogenicity: GMMA from engineered strains showed 600-fold lower monocyte activation compared to wild-type LPS .
Despite its inclusion in vaccine candidates, yebN’s specific role in Shigella pathogenesis or immune recognition remains uncharacterized. Critical gaps include:
Functional Studies: No data on yebN’s interaction with host cells or immune receptors.
Structural Insights: No crystallographic or cryo-EM studies to elucidate its membrane topology.
Comparative Analysis: Limited homology data across Shigella serotypes (e.g., S. flexneri, S. boydii).
Function: Likely functions as a manganese efflux pump.
KEGG: ssn:SSON_1339
Expression and purification of recombinant yebN protein requires specialized methodologies due to its membrane-associated nature. The recommended approach follows these steps:
Vector Selection: Use expression vectors containing strong inducible promoters suitable for membrane protein expression
Host Selection: E. coli strains specifically designed for membrane protein expression (such as C41, C43, or Lemo21) are preferred
Growth Conditions: Culture at lower temperatures (16-25°C) after induction to slow protein synthesis and facilitate proper folding
Extraction: Membrane protein extraction using detergents (commonly n-dodecyl-β-D-maltoside or LDAO)
Purification: Affinity chromatography using appropriate tags determined during the production process, followed by size exclusion chromatography
The purification process typically yields approximately 100 milligrams of membrane-associated proteins per liter of fermentation when optimized growth conditions are maintained with optical densities of 30-45 in a 5L fermenter system . Researchers should note that the tag type will be determined during the production process based on optimal expression conditions for this specific membrane protein .
Maintaining the structural integrity and functional activity of recombinant yebN protein requires specific storage conditions. The protein should be stored in a Tris-based buffer supplemented with 50% glycerol, which has been optimized specifically for this protein .
Long-term storage recommendations include:
Primary storage at -20°C
Extended storage at -20°C or -80°C
Avoiding repeated freeze-thaw cycles, which can significantly degrade membrane protein integrity
Preparing working aliquots that can be stored at 4°C for up to one week
These storage recommendations are based on empirical observations of membrane protein stability and are similar to those used for other Shigella membrane proteins such as yohJ, suggesting a generalizable approach for this class of proteins .
Recombinant yebN protein has significant potential in vaccine development research as part of broader outer membrane protein (OMP) vaccine strategies. The methodological approach involves:
Incorporation of yebN into Outer Membrane Particles (OMPs): yebN can be included in genetically derived outer membrane particles that consist of outer membrane lipids, proteins, and soluble periplasmic components .
Genetic Modification Approaches: Research can employ genetic manipulations to optimize immunogenicity, including:
Immunogenicity Assessment: Purified particles containing yebN have been shown to be highly immunogenic in mouse models, suggesting potential vaccine applications .
Production Scalability: High-density cultivation of bacteria for outer membrane particles yields approximately 100 mg of membrane-associated proteins per liter, indicating feasibility for scaled manufacturing processes .
This approach aligns with the Generalized Modules of Membrane Antigens (GMMA) strategy for vaccine production from Gram-negative bacteria, offering advantages in terms of immunogenicity and manufacturing scalability .
Comprehensive characterization of yebN protein interactions requires multiple complementary analytical approaches:
Structural Analysis Techniques:
X-ray crystallography with appropriate detergents or lipidic cubic phase crystallization
Cryo-electron microscopy for visualization in near-native membrane environments
NMR spectroscopy for dynamics studies (challenging for full-length membrane proteins)
Functional Interaction Studies:
Co-immunoprecipitation assays with potential binding partners
Bacterial two-hybrid systems adapted for membrane proteins
Cross-linking mass spectrometry to capture transient interactions
Isothermal titration calorimetry for binding kinetics
Membrane Integration Analysis:
Protease protection assays to determine topology
Fluorescence resonance energy transfer (FRET) to measure proximity to other membrane components
Site-directed spin labeling combined with electron paramagnetic resonance
The hydrophobic regions and transmembrane domains identified in the yebN sequence (MNITATVLLAFGMSMDAFAASVGKGATLHKPKFSEALRTGLIFGAVETLTPLIGWGMGML ASRFVLEWNHWIAFVLLIFLGGRMIIEGFRGADDEDEEPRRRHGFWLLVTTAIATSLDAM AVGVGLAFLQVNIIATALAIGCATLIMSTLGMMVGRFIGSIIGKKAEILGGLVLIGIGVQ ILWTHFHG) provide starting points for predicting protein-lipid and protein-protein interaction interfaces .
Site-directed mutagenesis provides powerful insights into structure-function relationships of yebN protein. The methodological approach should include:
Target Selection Strategy:
Conserved residues identified through multiple sequence alignments with homologous proteins
Predicted functional domains based on the 188-amino acid sequence
Transmembrane regions that may be involved in substrate transport or signaling
Mutation Design Considerations:
| Mutation Type | Application | Considerations |
|---|---|---|
| Alanine scanning | Identify essential residues | Systematic replacement of residues with alanine |
| Conservative substitutions | Probe chemical properties | Replace residues with chemically similar amino acids |
| Charge inversions | Test electrostatic interactions | Reverse charge (e.g., Asp→Arg) |
| Cysteine substitutions | Enable disulfide mapping | Introduce cysteines for cross-linking studies |
| Truncations | Domain mapping | Systematic deletion of protein regions |
When designing mutations, researchers should pay particular attention to the hydrophobic regions and transmembrane domains identified in the sequence analysis, as these are likely critical for proper membrane integration and function .
Comparative analysis of yebN with other Shigella sonnei membrane proteins reveals important structural and functional insights:
Structural Comparison:
yebN (188 amino acids) is classified as a UPF0059 membrane protein with predicted transmembrane regions
In comparison, the UPF0299 membrane protein yohJ (132 amino acids) shows a different structural organization while maintaining membrane localization
Both proteins contain hydrophobic transmembrane segments, but sequence analysis suggests different topological arrangements
Functional Context:
yebN belongs to a family of uncharacterized membrane proteins (UPF0059) whose precise functions remain to be fully elucidated
Other characterized Shigella membrane proteins like yegS (a probable lipid kinase) have more defined enzymatic activities
The membrane localization of these proteins suggests potential roles in bacterial-host interactions, virulence, or transport functions
Comparative Analysis Methodology:
Sequence alignment using BLAST or MUSCLE to identify conserved domains
Hydropathy profile analysis to compare transmembrane region distribution
Structural prediction using algorithms specifically optimized for membrane proteins
Phylogenetic analysis to determine evolutionary relationships
This comparative approach provides context for understanding yebN's potential roles within the broader membrane protein landscape of Shigella sonnei.
Studying yebN expression under varying environmental conditions requires sophisticated proteomic methodologies:
Sample Preparation Techniques:
Bacterial culture under defined stress conditions (pH, temperature, nutrient limitation)
Membrane fractionation using differential centrifugation
Protein extraction with specialized detergents optimized for membrane proteins
Quantitative Proteomic Methods:
| Method | Advantages | Limitations | Application to yebN |
|---|---|---|---|
| 2D-DIGE | Visual protein map | Limited for membrane proteins | Less optimal due to hydrophobicity |
| iTRAQ/TMT | Multiplexed analysis | Reporter ion interference | Good for relative quantification |
| SILAC | Accurate quantification | Requires metabolic labeling | Applicable in culture systems |
| Label-free quantification | No labeling required | Less precise | Good for initial screening |
| Selected Reaction Monitoring | Targeted, sensitive | Requires method development | Excellent for specific quantification |
Data Analysis Approach:
Normalization to account for membrane protein extraction variability
Statistical analysis to identify significant expression changes
Pathway analysis to contextualize expression changes
Correlation with transcriptomic data when available
Validation Methods:
Western blotting with specific antibodies
Targeted mass spectrometry using multiple reaction monitoring
Fluorescent protein fusions to monitor localization and expression
This proteomic workflow can reveal how yebN expression responds to environmental cues relevant to Shigella pathogenesis, potentially providing insights into its functional significance .
Developing high-throughput screening (HTS) approaches for yebN protein requires specialized methodologies due to its membrane nature:
Assay Development Strategy:
Fluorescence-based transport assays if yebN functions as a transporter
Cell-based reporter systems linking yebN activity to detectable signals
Thermal shift assays adapted for membrane proteins to detect ligand binding
Surface plasmon resonance with immobilized yebN in nanodiscs or liposomes
Compound Library Selection:
Fragment-based libraries for initial screening
Natural product libraries enriched for membrane-active compounds
Focused libraries based on known ligands of related membrane proteins
Diversity-oriented synthesis libraries to maximize chemical space coverage
Screening Workflow:
Primary screen at single concentration (typically 10 μM)
Dose-response curves for hits (typically 8-12 concentrations)
Counter-screens to eliminate false positives
Orthogonal assays to confirm mechanism of action
Hit Validation and Optimization:
Structure-activity relationship studies
Binding site identification through mutagenesis
Mode of action studies (antagonist vs. agonist)
Assessment of selectivity against related membrane proteins
This systematic approach enables identification of chemical probes that can help elucidate yebN function and potentially lead to new antimicrobial strategies targeting Shigella sonnei .
Several cutting-edge techniques are revolutionizing membrane protein research and could be applied to study yebN dynamics:
Advanced Structural Biology Approaches:
Single-particle cryo-electron microscopy to capture different conformational states
Time-resolved X-ray crystallography to observe conformational changes
Hydrogen-deuterium exchange mass spectrometry to map dynamic regions
Nuclear magnetic resonance relaxation dispersion to quantify microsecond-millisecond dynamics
Advanced Microscopy Techniques:
Single-molecule FRET to track conformational changes in real-time
High-speed atomic force microscopy to visualize structural dynamics
Super-resolution microscopy to map protein distribution in bacterial membranes
Correlative light and electron microscopy for integrated structural and functional studies
Computational Methods:
Molecular dynamics simulations to predict conformational changes
Enhanced sampling techniques to access longer timescales
Markov state modeling to identify key conformational states
Machine learning approaches to predict structure from sequence
Membrane Mimetic Systems:
Nanodiscs for controlled membrane environment studies
Lipid cubic phases for crystallization and functional studies
Cell-free expression systems for direct incorporation into membranes
Polymer-based membrane mimetics for stability in harsh conditions
Application of these emerging techniques to yebN would provide unprecedented insights into how this membrane protein functions within the bacterial membrane environment and potentially reveal new approaches for targeting Shigella sonnei infections .
Ensuring the quality of recombinant yebN protein preparations requires rigorous quality control protocols:
Purity Assessment Methods:
SDS-PAGE with Coomassie staining (target: >90% purity)
Western blot analysis with tag-specific or protein-specific antibodies
Size exclusion chromatography to assess aggregation state
Mass spectrometry to confirm protein identity and detect modifications
Structural Integrity Verification:
| Method | Information Provided | Acceptance Criteria |
|---|---|---|
| Circular dichroism | Secondary structure content | Consistent α-helical content between batches |
| Fourier-transform infrared spectroscopy | Secondary structure in membrane environment | Characteristic amide I and II bands |
| Intrinsic fluorescence | Tertiary structure assessment | Consistent emission maximum and intensity |
| Differential scanning calorimetry | Thermal stability | Reproducible transition temperature |
Functional Validation:
Reconstitution into liposomes to verify membrane integration
Activity assays based on predicted function (if known)
Binding assays with known interaction partners
Patch-clamp electrophysiology if ion channel activity is suspected
Stability Monitoring:
Accelerated stability studies at elevated temperatures
Regular testing of stored samples at defined time points
Monitoring by SEC-MALS to detect aggregation over time
Isotope labeling strategies enable sophisticated NMR studies of yebN structure and dynamics:
Labeling Strategy Selection:
Uniform 15N labeling for backbone assignment and dynamics
13C/15N double labeling for complete structure determination
Selective amino acid labeling to reduce spectral complexity
Methyl-specific labeling (Ile, Leu, Val) for studying large membrane proteins
Segmental labeling for focusing on specific domains
Expression Optimization for Labeled Protein:
NMR Experimental Approaches:
TROSY-based experiments for optimal sensitivity with membrane proteins
Solid-state NMR for studying yebN in lipid bilayers
Paramagnetic relaxation enhancement to obtain long-range distance constraints
Residual dipolar coupling measurements for orientation information
Membrane Mimetic Selection for NMR:
Detergent micelles (DDM, DPC) for solution NMR
Bicelles for solution or solid-state NMR
Nanodiscs for a more native-like membrane environment
Oriented bilayers for solid-state NMR
These approaches allow researchers to obtain atomic-level insights into yebN structure, dynamics, and interactions, contributing to a mechanistic understanding of its function in Shigella sonnei .